The incretin enhancer vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed -cell function in patients with type 2 diabetes
Research output: Contribution to journal › Journal article › Research
| Original language | English |
|---|---|
| Journal | Journal of Clinical Endocrinology and Metabolism |
| Issue number | 90 |
| Pages (from-to) | 4888-4894 |
| ISSN | 0021-972X |
| Publication status | Published - 2005 |
ID: 70520